Form 4: cbdMD Director Receives Equity Compensation Grant
Director Equity Compensation Disclosure
Director Sybil Nichole Swift was granted 1,572 restricted stock units as compensation for board services.
Summary
- Director Sybil Nichole Swift acquired 1,572 restricted stock units (RSUs) of cbdMD, Inc. common stock.
- The transaction occurred on April 14, 2026, at a price of $0 per share as part of director compensation.
- Following this transaction, the director's total beneficial ownership increased to 4,145 shares.
- The RSUs vest in four equal quarterly installments starting June 30, 2026, through March 31, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation that does not signal a change in company strategy or financial health.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized compensation structure approved by the Compensation, Corporate Governance and Nominating Committee.
Negatives
- None identified in this filing.
Risks
- General market risks associated with equity ownership in the cannabis/CBD sector.
- Potential dilution of existing shareholders, though the amount is immaterial.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.
Management Comments
- The grant was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee.
Industry Context
StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice designed to incentivize long-term value creation, particularly in volatile sectors like the CBD industry.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) for director compensation is consistent with standard practices for small-cap publicly traded companies.
- The vesting schedule over one year is a common retention mechanism for board members.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Issuance of restricted stock units to a director under the 2021 or 2025 Equity Compensation Plan. | 04/14/2026 | Minimal impact on corporate governance; aligns director incentives with shareholder interests. |
Stakeholder Impact
- Shareholders: Minor dilution impact, though standard for board compensation.
- Director: Increased equity stake in the company.
Next Steps
- Vesting of the first tranche of RSUs on June 30, 2026.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Date of the equity grant transaction. |
| 04/16/2026 | Date of filing. |
| 06/30/2026 | First quarterly vesting date. |
| 03/31/2027 | Final quarterly vesting date. |
Keywords
cbdMD, YCBD, Form 4, Director Compensation, Restricted Stock Units, Insider Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.